Delivery Order SPE2DB22D3004-SPE2DB25FSF28
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,707.63 to AmerisourceBergen Drug Corp for the supply of Viberzi 100 mg tablets (60-count) on August 19, 2025, with an ultimate completion date of August 20, 2025. The contract utilizes firm fixed pricing and is classified as a non-set-aside competitive award. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,707.63 for 60 tablets of Viberzi 100 mg, with a completion date of July 28, 2025. This competitively awarded, firm fixed-price contract represents a pediatric order from the pharmaceutical distributor's extensive portfolio of federal medical supply contracts. The contract was executed on July 25, 2025, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $3,689.52 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Viberzi 75 mg tablets (60-count packages). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,881.75 to AmerisourceBergen Drug Corp for 60 tablets of Viberzi 100 mg on August 14, 2025, with completion scheduled for August 15, 2025. This competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The pharmaceutical will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Viberzi 100 mg tablets (60-count units) with a ceiling value of $1,852.16. This is a firm fixed price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract is classified as a child order under the parent SPE2DX IDC, valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a $2,161.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Viberzi 100 mg, a pharmaceutical product for gastrointestinal treatment. This non-set-aside order was competitively awarded on August 22, 2025, with an ultimate completion date of August 25, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,707.63 firm fixed price contract is for the delivery of Viberzi 100 mg Tablets in quantities of 60. The contract has a performance period ending on May 29, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which allows the company to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 mg Viberzi tablets. The $2,648.37 firm-fixed-price contract has an ultimate completion date of October 10, 2024. AmerisourceBergen has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by the DLA and other agencies to provide a wide range of essential pharmaceutical products and medical supplies to...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm-fixed price delivery order contract worth $1,258.54 to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4,566,066,666 Viberzi 100 MG tablets in 60 count packages. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, under which AmerisourceBergen provides a comprehensive range of pharmaceutical and medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,707.63 to AmerisourceBergen Drug Corp for 60 tablets of Viberzi 100 mg, a pharmaceutical product used to treat irritable bowel syndrome. This competitively awarded, firm fixed-price delivery order was issued on August 7, 2025, with an ultimate completion date of August 8, 2025. The award was performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, and represents a child contract under...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FSF28Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Viberzi 100 mg tablets (60-count) under a firm fixed-price contract valued at $1,734.24. This is a competitively awarded, non-set-aside delivery order with an ultimate completion date of August 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The SPE2DX indefinite delivery vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. This prime contract encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. AmerisourceBergen's federal contract portfolio demonstrates its capability to fulfill diverse medical procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The firm's consistent receipt of competitively awarded delivery orders reflects its established position as a critical vendor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/28/25 |